Loading clinical trials...
Loading clinical trials...
Peripheral Blood Mononuclear Cell Donation Protocol for Tumor Immunotherapy Study of UCAR-T Cells
Conditions
Interventions
Peripheral blood mononuclear cell apheresis
Locations
1
China
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Start Date
October 1, 2019
Primary Completion Date
March 31, 2020
Completion Date
June 30, 2020
Last Updated
September 17, 2019
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions